Nature's Sunshine (NASDAQ:NATR) Beats Q4 CY2025 Sales Expectations

Wellness products company Nature’s Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q4 CY2025, with sales up 4.7% year on year to $123.8 million. The company’s full-year revenue guidance of $507.5 million at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $0.30 per share was 57.9% above analysts’ consensus estimates.

Is now the time to buy Nature's Sunshine? Find out by accessing our full research report, it’s free.

“We finished a record year in sales and delivered our second‑best quarter ever and our largest Q4 on record, with sales and adjusted EBITDA up 5% and 16%, respectively,” said Ken Romanzi, CEO of Nature’s Sunshine.

Company Overview

Started on a kitchen table in Utah, Nature’s Sunshine (NASDAQ:NATR) manufactures and sells nutritional and personal care products.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.

With $480.1 million in revenue over the past 12 months, Nature's Sunshine is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers.

As you can see below, Nature's Sunshine’s 4.4% annualized revenue growth over the last three years was tepid. This shows it failed to generate demand in any major way and is a rough starting point for our analysis.

This quarter, Nature's Sunshine reported modest year-on-year revenue growth of 4.7% but beat Wall Street’s estimates by 1.8%.

Looking ahead, sell-side analysts expect revenue to grow 3.1% over the next 12 months, similar to its three-year rate. This projection doesn't excite us and suggests its products will see some demand headwinds.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Cash Is King

Although earnings are undoubtedly valuable for assessing company performance, we believe cash is king because you can’t use accounting profits to pay the bills.

Nature's Sunshine has shown mediocre cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 4.6%, below what we’d expect for a consumer staples business.

Taking a step back, an encouraging sign is that Nature's Sunshine’s margin expanded by 2.9 percentage points over the last year. The company’s improvement shows it’s heading in the right direction, and we can see it became a less capital-intensive business because its free cash flow profitability rose while its operating profitability was flat.

Nature's Sunshine’s free cash flow clocked in at $7.56 million in Q4, equivalent to a 6.1% margin. The company’s cash profitability regressed as it was 2.3 percentage points lower than in the same quarter last year, but it’s still above its two-year average. We wouldn’t read too much into this quarter’s decline because investment needs can be seasonal, causing short-term swings. Long-term trends are more important.

Key Takeaways from Nature's Sunshine’s Q4 Results

It was good to see Nature's Sunshine beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a solid print. The stock traded up 2.9% to $25.80 immediately after reporting.

Nature's Sunshine put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).